Cargando…

Genetic factors underlying tacrolimus intolerance after liver transplantation

BACKGROUND: Tacrolimus (FK506) is the cornerstone of immunosuppression after liver transplantation (LT), however, clinically, switching from FK506 to cyclosporine (SFTC) is common in LT patients with tacrolimus intolerance. The aim of this study was to investigate the genetic risk of patients with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yuan, Wang, Rui, Wen, Peizhen, An, Wenbin, Zheng, Jinxin, Zhang, Tao, Zhang, Pengshan, Wang, Haoyu, Zou, Fan, Pan, Hui, Fan, Junwei, Peng, Zhihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562471/ https://www.ncbi.nlm.nih.gov/pubmed/36248867 http://dx.doi.org/10.3389/fimmu.2022.944442

Ejemplares similares

Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation
por: Shi, Baojie, et al.
Publicado: (2022)

Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
por: Chen, Dawei, et al.
Publicado: (2013)

Genome-Wide Association Study of Tacrolimus Pharmacokinetics Identifies Novel Single Nucleotide Polymorphisms in the Convalescence and Stabilization Periods of Post-transplant Liver Function
por: Liu, Yuan, et al.
Publicado: (2019)

A new donors’ CYP3A5 and recipients’ CYP3A4 cluster predicting tacrolimus disposition, and new-onset hypertension in Chinese liver transplant patients
por: Liu, Yuan, et al.
Publicado: (2017)

Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation
por: Song, Turun, et al.
Publicado: (2019)

The CYP3A5 genotypes of both liver transplant recipients and donors influence the time‐dependent recovery of tacrolimus clearance during the early stage following transplantation
por: Huang, Li, et al.
Publicado: (2021)

Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation
por: Zhang, Tao, et al.
Publicado: (2017)

The prognostic value of the GPAT/AGPAT gene family in hepatocellular carcinoma and its role in the tumor immune microenvironment
por: Wen, Peizhen, et al.
Publicado: (2023)

Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance
por: Chen, Quanyu, et al.
Publicado: (2023)

The influence of recipient SLCO1B1 rs2291075 polymorphism on tacrolimus dose–corrected trough concentration in the early period after liver transplantation
por: Wu, Yi, et al.
Publicado: (2021)

Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients
por: Zhang, Xiaoqing, et al.
Publicado: (2017)

Regulatory T cells in lung disease and transplantation
por: Lao, Peizhen, et al.
Publicado: (2023)

Acute symptomatic seizure due to tacrolimus-related encephalopathy after liver transplantation: two case reports
por: Li, Yao, et al.
Publicado: (2019)

Tacrolimus-induced Ascites after Liver Transplant
por: Hosseini, M., et al.
Publicado: (2018)

Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma
por: Liao, Jian-Hua, et al.
Publicado: (2017)

Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation
por: Park, Yohan, et al.
Publicado: (2022)

The Population Pharmacokinetic Models of Tacrolimus in Chinese Adult Liver Transplantation Patients
por: Zhu, Liqin, et al.
Publicado: (2014)

Lumacaftor/ivacaftor initiation in two liver transplantation patients under tacrolimus and antifungal azoles
por: Chouchane, Ikrame, et al.
Publicado: (2019)

Effects of CYP3A5 Genotypes on Thrombocytopenia in Liver Transplantation Patients Treated with Tacrolimus
por: Guo, Zhe, et al.
Publicado: (2023)

Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
por: Bzeizi, Khalid Ibrahim, et al.
Publicado: (2021)

Clinical Pharmacokinetics of Tacrolimus in Iranian Liver Transplant Recipients
por: Nasiri-Toosi, Zahra, et al.
Publicado: (2014)

Gout Due to Tacrolimus in a Liver Transplant Recipient
por: Afridi, Summia Matin, et al.
Publicado: (2019)

Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation
por: Park, Yohan, et al.
Publicado: (2021)

Case Report: Ofatumumab treatment in a patient with rituximab-intolerant refractory autoimmune GFAP astrocytopathy
por: Cao, Shugang, et al.
Publicado: (2023)

Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study
por: Wang, Pusen, et al.
Publicado: (2016)

Intraoperative Cryoprecipitate Transfusion and Its Association with the Incidence of Biliary Complications after Liver Transplantation-A Retrospective Cohort Study
por: Liu, Shuang, et al.
Publicado: (2013)

Tacrolimus-induced cerebral blindness in a liver transplant patient
por: Tamhankar, Madhura A., et al.
Publicado: (2016)

Network pharmacology-based analysis of the role of tacrolimus in liver transplantation
por: Chen, Lijian, et al.
Publicado: (2021)

Tacrolimus toxicity-related chorea in an infant after liver transplantation
por: Kahveci, Fevzi, et al.
Publicado: (2022)

Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
por: Rodríguez‐Perálvarez, Manuel, et al.
Publicado: (2022)

Hepatic sinusoidal obstruction syndrome due to tacrolimus in a liver-transplantation recipient
por: Zhou, Shuang-Nan, et al.
Publicado: (2020)

The Effects of Tacrolimus on Tissue-Specific, Protein-Level Inflammatory Networks in Vascularized Composite Allotransplantation
por: Aral, Ali Mubin, et al.
Publicado: (2021)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

The efficacy and safety of tacrolimus on top of glucocorticoids in the management of IIM-ILD: A retrospective and prospective study
por: Chen, Yuxue, et al.
Publicado: (2022)

Single-cell RNA-seq revealing the immune features of donor liver during liver transplantation
por: Shan, Yi, et al.
Publicado: (2023)

The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells
por: Wallin, Elizabeth F., et al.
Publicado: (2018)

The pharmacokinetic study of tacrolimus and Wuzhi capsule in Chinese liver transplant patients
por: Qu, Jinlong, et al.
Publicado: (2022)

Effect of Donor and Recipient ABH-Secretor Status on ABO-Incompatible Living Donor Kidney Transplantation
por: Zhang, Fan, et al.
Publicado: (2021)

C7 genotype of the donor may predict early bacterial infection after liver transplantation
por: Zhong, Lin, et al.
Publicado: (2016)

Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients during the Early Stages Post-Lung Transplantation
por: Cui, Yi-Fan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v5a3uoklo1rpvqc6aclcs6rfr7